[Treatment of acute pancreatitis with glucagon. Report on a double blind study]. 1976

H K Dürr, and O Zelder, and D Maroske, and J C Bode

UI MeSH Term Description Entries
D008297 Male Males
D010195 Pancreatitis INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis. Acute Edematous Pancreatitis,Acute Pancreatitis,Pancreatic Parenchyma with Edema,Pancreatic Parenchymal Edema,Pancreatitis, Acute,Pancreatitis, Acute Edematous,Peripancreatic Fat Necrosis,Acute Edematous Pancreatitides,Acute Pancreatitides,Edema, Pancreatic Parenchymal,Edematous Pancreatitides, Acute,Edematous Pancreatitis, Acute,Fat Necrosis, Peripancreatic,Necrosis, Peripancreatic Fat,Pancreatic Parenchymal Edemas,Pancreatitides, Acute,Pancreatitides, Acute Edematous,Parenchymal Edema, Pancreatic,Peripancreatic Fat Necroses
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute

Related Publications

H K Dürr, and O Zelder, and D Maroske, and J C Bode
November 1980, Canadian journal of surgery. Journal canadien de chirurgie,
H K Dürr, and O Zelder, and D Maroske, and J C Bode
May 1968, Nordisk medicin,
H K Dürr, and O Zelder, and D Maroske, and J C Bode
April 1978, Archives of internal medicine,
H K Dürr, and O Zelder, and D Maroske, and J C Bode
October 1980, The New England journal of medicine,
H K Dürr, and O Zelder, and D Maroske, and J C Bode
September 1980, Revista clinica espanola,
H K Dürr, and O Zelder, and D Maroske, and J C Bode
May 1979, Minerva chirurgica,
H K Dürr, and O Zelder, and D Maroske, and J C Bode
October 1979, Gastroenterology,
H K Dürr, and O Zelder, and D Maroske, and J C Bode
September 1985, Scandinavian journal of gastroenterology,
H K Dürr, and O Zelder, and D Maroske, and J C Bode
January 1975, Scandinavian journal of gastroenterology,
H K Dürr, and O Zelder, and D Maroske, and J C Bode
June 1979, Revista espanola de las enfermedades del aparato digestivo,
Copied contents to your clipboard!